| Literature DB >> 6779243 |
Abstract
Serologic screening of pregnant women to prevent congenital syphilis has been obligatory in Norway since 1948. Today the incidence of unrecognized, untreated maternal syphilis is approximately 0.2 per 1000 pregnancies. A cost-benefit model is applied to the current prenatal screening programme in Norway. Although may of the benefit parameters are given only an approximate value, or are not valued at all, it was found that the benefit-cost ratio was nearly 2 (1.9), indicating that the economic benefits or savings to the society represent twice the cost of the preventive programme.Entities:
Keywords: Congenital Abnormalities--cost; Congenital Abnormalities--prevention and control; Cost Benefit Analysis; Delivery Of Health Care; Developed Countries; Diseases; Europe; Evaluation; Government Sponsored Programs--cost; Health; Health Services; Infections; Maternal Health Services; Maternal-child Health Services; Mathematical Model; Models, Theoretical; Neonatal Diseases And Abnormalities; Northern Europe; Norway; Organization And Administration; Prenatal Care--cost; Primary Health Care; Programs; Quantitative Evaluation; Reproductive Tract Infections; Research Methodology; Scandinavia; Sexually Transmitted Diseases--prevention and control
Mesh：
Year: 1980 PMID： 6779243
Source DB: PubMed Journal: NIPH Ann ISSN： 0332-5652